Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence / Michael Soyka en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 317-324 Título : Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence : Results from a placebo-controlled, double-blind trial Tipo de documento: texto impreso Autores: Michael Soyka, Autor ; Gabriele Koller, Autor ; Peggy Schmidt, Autor Fecha de publicación: 2023 Artículo en la página: pp. 317-324 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Alcoholismo, Índice de masa corporal, Piperidinas, Pirazoles. Resumen: Multiple lines of evidence suggest that the endocannabinoid system is implicated in the development of alcohol dependence. In addition, in animal models, the cannabinoid receptor 1 blocker rimonabant was found to decrease alcohol consumption, possibly by indirect modulation of dopaminergic neurotransmission. Link: ./index.php?lvl=notice_display&id=30853 [artículo] Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence : Results from a placebo-controlled, double-blind trial [texto impreso] / Michael Soyka, Autor ; Gabriele Koller, Autor ; Peggy Schmidt, Autor . - 2023 . - pp. 317-324. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 317-324 Etiquetas: Alcoholismo, Índice de masa corporal, Piperidinas, Pirazoles. Resumen: Multiple lines of evidence suggest that the endocannabinoid system is implicated in the development of alcohol dependence. In addition, in animal models, the cannabinoid receptor 1 blocker rimonabant was found to decrease alcohol consumption, possibly by indirect modulation of dopaminergic neurotransmission. Link: ./index.php?lvl=notice_display&id=30853

---

1 (1 - 1 / 1) Por página: 25 50 100 200